Evaluating the performance of fibronectin 1 (FN1), integrin α4β1 (ITGA4), syndecan-2 (SDC2), and glycoprotein CD44 as the potential biomarkers of oral squamous cell carcinoma (OSCC)

References

• Andreoli V, Cittadella R, Valentino P, Condino F, La Russa A, Liguori M, Manna I, Spadafora P, Nisticò R, Pirritano D, Clodomiro A, Quattrone A. (2007). The role of VLA4 polymorphisms in multiple sclerosis: An association study. J Neuroimmunol 189:125–128.
   PubMedGoogle Scholar
• Anwar AR, Walsh GM, Cromwell O, Kay AB, Wardlaw AJ. (1994). Adhesion to fibronectin primes eosinophils via α4β1 (VLA-4). Immunology 82:222–228.
   PubMed Web of Science ®Google Scholar
• Assimakopoulos D, Kolettas E, Patrikakos G, Evangelou A. (2002). The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas. Histol Histopathol 17:1269–1281.
   PubMed Web of Science ®Google Scholar
• Beauvais DM, Rapraeger AC. (2004). Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2:3.
   PubMedGoogle Scholar
• Brahmachari S, Pahan K. (2010). Gender-specific expression of β1 integrin of VLA-4 in myelin basic protein-primed T cells: Implications for gender bias in multiple sclerosis. J Immunol 184:6103–6113.
   PubMed Web of Science ®Google Scholar
• Buggins AG, Levi A, Gohil S, Fishlock K, Patten PE, Calle Y, Yallop D, Devereux S. (2011). Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9. Br J Haematol 154:216–222.
   PubMed Web of Science ®Google Scholar
• Chan BM, Elices MJ, Murphy E, Hemler ME. (1992). Adhesion to vascular cell adhesion molecule 1 and fibronectin. Comparison of α 4 β 1 (VLA-4) and α 4 β 7 on the human B cell line JY. J Biol Chem 267:8366–8370.
   PubMed Web of Science ®Google Scholar
• Chang HW, Cheng CA, Gu DL, Chang CC, Su SH, Wen CH, Chou YC, Chou TC, Yao CT, Tsai CL, Cheng CC. (2008). High-throughput avian molecular sexing by SYBR green-based real-time PCR combined with melting curve analysis. BMC Biotechnol 8:12.
   PubMedGoogle Scholar
• Chang E, Park DI, Kim YJ, Kim BK, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Kim HD, Kim DH, Kim YH. (2010). Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: A preliminary report in Korean patients. Hepatogastroenterology 57:720–727.
   PubMedGoogle Scholar
• Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Jain S, Singh M. (2010). Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population. Biomarkers 15:684–692.
   PubMed Web of Science ®Google Scholar
• Chaudhary AK, Pandya S, Mehrotra R, Singh M, Singh M. (2011). Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population. Biomarkers 16:577–586.
   PubMed Web of Science ®Google Scholar
• Chien MH, Ying TH, Hsieh YH, Lin CH, Shih CH, Wei LH, Yang SF. (2012). Tumor-associated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosis. Oral Oncol 48:417–423.
   PubMed Web of Science ®Google Scholar
• Chiquet BT, Hashmi SS, Henry R, Burt A, Mulliken JB, Stal S, Bray M, Blanton SH, Hecht JT. (2009). Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palate. Eur J Hum Genet 17:195–204.
   PubMedGoogle Scholar
• Choi Y, Kim H, Chung H, Hwang JS, Shin JA, Han IO, Oh ES. (2010). Syndecan-2 regulates cell migration in colon cancer cells through Tiam1-mediated Rac activation. Biochem Biophys Res Commun 391:921–925.
   PubMed Web of Science ®Google Scholar
• Chong HC, Tan CK, Huang RL, Tan NS. (2012). Matricellular proteins: A sticky affair with cancers. J Oncol 2012:351089.
   PubMedGoogle Scholar
• Desgrosellier JS, Cheresh DA. (2010). Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer 10:9–22.
   PubMed Web of Science ®Google Scholar
• Devriese LA, Bosma AJ, van de Heuvel MM, Heemsbergen W, Voest EE, Schellens JH. (2012). Circulating tumor cell detection in advanced non-small cell lung cancer patients by multi-marker QPCR analysis. Lung Cancer 75:242–247.
   PubMedGoogle Scholar
• Elahi M, Rakhshan V, Ghasemian NT, Moshref M. (2012). Prognostic value of transforming growth factor β 1 [TGF-ß1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma. Biomarkers 17:21–27.
   PubMed Web of Science ®Google Scholar
• Essner JJ, Chen E, Ekker SC. (2006). Syndecan-2. Int J Biochem Cell Biol 38:152–156.
   PubMed Web of Science ®Google Scholar
• Fabris M, Quartuccio L, Salvin S, Pozzato G, De Re V, Mazzaro C, Ferri C, Baldini C, De Vita S. (2008). Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. Ann Rheum Dis 67:80–83.
   PubMed Web of Science ®Google Scholar
• Faria PC, Sena AA, Nascimento R, Carvalho WJ, Loyola AM, Silva SJ, Durighetto AF, Oliveira AD, Oliani SM, Goulart LR. (2010). Expression of annexin A1 mRNA in peripheral blood from oral squamous cell carcinoma patients. Oral Oncol 46:25–30.
   PubMedGoogle Scholar
• Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, Hamilton K, Singal R, Goodwin WJ. (2007). Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 16:1348–1355.
   PubMed Web of Science ®Google Scholar
• Gao K, Zhou H, Zhang L, Lee JW, Zhou Q, Hu S, Wolinsky LE, Farrell J, Eibl G, Wong DT. (2009). Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer. PLoS ONE 4:e5875.
   PubMed Web of Science ®Google Scholar
• Garmy-Susini B, Avraamides CJ, Schmid MC, Foubert P, Ellies LG, Barnes L, Feral C, Papayannopoulou T, Lowy A, Blair SL, Cheresh D, Ginsberg M, Varner JA. (2010). Integrin α4β1 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res 70:3042–3051.
   PubMed Web of Science ®Google Scholar
• Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M (eds.). (2002). AJCC Cancer Staging Manual. New York: Springer.
   Google Scholar
• Grimm M, Krimmel M, Polligkeit J, Alexander D, Munz A, Kluba S, Keutel C, Hoffmann J, Reinert S, Hoefert S. (2012). ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma. Eur J Cancer. [Epub ahead of print] PMID: 22784549. DOI: 10.1016/j.ejca.2012.05.027.
   PubMedGoogle Scholar
• Gupta N, Kakkar N, Vasishta RK. (2006). Pattern of fibronectin in hepatocellular carcinoma and its significance. Indian J Pathol Microbiol 49:362–364.
   PubMedGoogle Scholar
• Han I, Park H, Oh ES. (2004). New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells. J Mol Histol 35:319–326.
   PubMedGoogle Scholar
• Heymann GA, Carstanjen D, Kiesewetter H, Salama A. (2004). Polymorphism of the α4-subunit of VLA-4 integrin and bone marrow transplantation. Haematologica 89:882–884.
   PubMedGoogle Scholar
• Huang X, Xiao DW, Xu LY, Zhong HJ, Liao LD, Xie ZF, Li EM. (2009). Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma. Oncol Rep 21:1123–1129.
   PubMedGoogle Scholar
• Iczkowski KA. (2010). Cell adhesion molecule CD44: Its functional roles in prostate cancer. Am J Transl Res 3:1–7.
   PubMed Web of Science ®Google Scholar
• Jalkanen S, Jalkanen M. (1992). Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116:817–825.
   PubMed Web of Science ®Google Scholar
• Jerhammar F, Ceder R, Garvin S, Grénman R, Grafström RC, Roberg K. (2011). Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. Cancer Biol Ther 10:1244–1251.
   Google Scholar
• Judd NP, Winkler AE, Murillo-Sauca O, Brotman JJ, Law JH, Lewis JS Jr, Dunn GP, Bui JD, Sunwoo JB, Uppaluri R. (2012). ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Res 72:365–374.
   PubMed Web of Science ®Google Scholar
• Khan ZA, Caurtero J, Barbin YP, Chan BM, Uniyal S, Chakrabarti S. (2005). ED-B fibronectin in non-small cell lung carcinoma. Exp Lung Res 31:701–711.
   PubMed Web of Science ®Google Scholar
• Kim SH, Turnbull J, Guimond S. (2011). Extracellular matrix and cell signalling: The dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 209:139–151.
   PubMed Web of Science ®Google Scholar
• Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. (1995). Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 24:450–453.
   PubMed Web of Science ®Google Scholar
• Kosunen A, Pirinen R, Ropponen K, Pukkila M, Kellokoski J, Virtaniemi J, Sironen R, Juhola M, Kumpulainen E, Johansson R, Nuutinen J, Kosma VM. (2007). CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. Oral Oncol 43:51–59.
   PubMedGoogle Scholar
• Kunimura T, Yoshida T, Sugiyama T, Morohoshi T. (2009). The Relationships Between Loss of Standard CD44 Expression and Lymph Node, Liver Metastasis in T3 Colorectal Carcinoma. J Gastrointest Cancer 40:115–118.
   PubMedGoogle Scholar
• Kurtova AV, Tamayo AT, Ford RJ, Burger JA. (2009). Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): Importance for interactions with the stromal microenvironment and specific targeting. Blood 113:4604–4613.
   PubMed Web of Science ®Google Scholar
• Kusano Y, Oguri K, Nagayasu Y, Munesue S, Ishihara M, Saiki I, Yonekura H, Yamamoto H, Okayama M. (2000). Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin α5β1: Structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin. Exp Cell Res 256:434–444.
   PubMed Web of Science ®Google Scholar
• Kusano Y, Yoshitomi Y, Munesue S, Okayama M, Oguri K. (2004). Cooperation of syndecan-2 and syndecan-4 among cell surface heparan sulfate proteoglycans in the actin cytoskeletal organization of Lewis lung carcinoma cells. J Biochem 135:129–137.
   PubMedGoogle Scholar
• Labat-Robert J. (2012). Cell-Matrix interactions, the role of fibronectin and integrins. A survey. Pathol Biol 60:15–19.
   PubMed Web of Science ®Google Scholar
• Le Bras GF, Allison GL, Richards NF, Ansari SS, Washington MK, Andl CD. (2011). CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion. PLoS ONE 6:e27063.
   Google Scholar
• Lee KM, Han W, Kim JB, Shin I, Ko E, Park IA, Lee DS, Oh K, Noh DY. (2012). The CD49d+/high subpopulation from isolated human breast sarcoma spheres possesses tumor-initiating ability. Int J Oncol 40:665–672.
   PubMedGoogle Scholar
• Lesley J, Hyman R, Kincade PW. (1993). CD44 and its interaction with extracellular matrix. Adv Immunol 54:271–335.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408.
   PubMed Web of Science ®Google Scholar
• Luizon MR, de Almeida Belo V. (2012). Matrix metalloproteinase (MMP)-2 and MMP-9 polymorphisms and haplotypes as disease biomarkers. Biomarkers 17:286–288.
   PubMed Web of Science ®Google Scholar
• Marhaba R, Freyschmidt-Paul P, Zöller M. (2006). In vivo CD44-CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance. Eur J Immunol 36:3017–3032.
   PubMed Web of Science ®Google Scholar
• Markopoulos AK. (2012). Current aspects on oral squamous cell carcinoma. Open Dent J 6:126–130.
   PubMedGoogle Scholar
• Marzioni D, Lorenzi T, Mazzucchelli R, Capparuccia L, Morroni M, Fiorini R, Bracalenti C, Catalano A, David G, Castellucci M, Muzzonigro G, Montironi R. (2009). Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. Int J Immunopathol Pharmacol 22:627–638.
   PubMedGoogle Scholar
• Mima K, Okabe H, Ishimoto T, Hayashi H, Nakagawa S, Kuroki H, Watanabe M, Beppu T, Tamada M, Nagano O, Saya H, Baba H. (2012). CD44s regulates the TGF-ß-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Res 72:3414–3423.
   PubMed Web of Science ®Google Scholar
• Munesue S, Yoshitomi Y, Kusano Y, Koyama Y, Nishiyama A, Nakanishi H, Miyazaki K, Ishimaru T, Miyaura S, Okayama M, Oguri K. (2007). A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis. J Biol Chem 282:28164–28174.
   PubMed Web of Science ®Google Scholar
• Nückel H, Switala M, Collins CH, Sellmann L, Grosse-Wilde H, Dührsen U, Rebmann V. (2009). High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia. Clin Immunol 131:472–480.
   PubMed Web of Science ®Google Scholar
• Popovic A, Demirovic A, Spajic B, Stimac G, Kruslin B, Tomas D. (2010). Expression and prognostic role of syndecan-2 in prostate cancer. Prostate Cancer Prostatic Dis 13:78–82.
   PubMedGoogle Scholar
• Rajarajan A, Bloor BK, Desai H, Stokes A, Odell EW. (2008). Variant CD44 expression by human fibroblasts. Biomarkers 13:307–318.
   PubMed Web of Science ®Google Scholar
• Rebhun RB, Cheng H, Gershenwald JE, Fan D, Fidler IJ, Langley RR. (2010). Constitutive expression of the α4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma. Neoplasia 12:173–182.
   PubMedGoogle Scholar
• Ryu HY, Lee J, Yang S, Park H, Choi S, Jung KC, Lee ST, Seong JK, Han IO, Oh ES. (2009). Syndecan-2 functions as a docking receptor for pro-matrix metalloproteinase-7 in human colon cancer cells. J Biol Chem 284:35692–35701.
   PubMedGoogle Scholar
• Ryu MH, Park HM, Chung J, Lee CH, Park HR. (2010). Hypoxia-inducible factor-1α mediates oral squamous cell carcinoma invasion via upregulation of α5 integrin and fibronectin. Biochem Biophys Res Commun 393:11–15.
   PubMedGoogle Scholar
• Saito Y, Owaki T, Matsunaga T, Saze M, Miura S, Maeda M, Eguchi M, Tanaka R, Taira J, Kodama H, Goto S, Niitsu Y, Terada H, Fukai F. (2010). Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4. J Biol Chem 285:7006–7015.
   PubMedGoogle Scholar
• Salani R, Neuberger I, Kurman RJ, Bristow RE, Chang HW, Wang TL, Shih IeM. (2007). Expression of extracellular matrix proteins in ovarian serous tumors. Int J Gynecol Pathol 26:141–146.
   PubMedGoogle Scholar
• Sengupta S, Nandi S, Hindi ES, Wainwright DA, Han Y, Lesniak MS. (2010). Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model. Neoplasia 12:837–847.
   PubMed Web of Science ®Google Scholar
• Siemianowicz K, Gminski J, Francuz T, Syzdol M, Polanska D, Machalski M, Brulinski K, Magiera-Molendowska H. (2001). Fibronectin gene polymorphism in patients with lung cancer. Oncol Rep 8:1289–1292.
   PubMedGoogle Scholar
• Singh RD, Haridas N, Patel JB, Shah FD, Shukla SN, Shah PM, Patel PS. (2010). Matrix metalloproteinases and their inhibitors: Correlation with invasion and metastasis in oral cancer. Indian J Clin Biochem 25:250–259.
   PubMedGoogle Scholar
• Slack-Davis JK, Atkins KA, Harrer C, Hershey ED, Conaway M. (2009). Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res 69:1469–1476.
   PubMed Web of Science ®Google Scholar
• Steffens S, Schrader AJ, Vetter G, Eggers H, Blasig H, Becker J, Kuczyk MA, Serth J. (2012). Fibronectin 1 protein expression in clear cell renal cell carcinoma. Oncol Lett 3:787–790.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ, von Mering C. (2011). The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39:D561–D568.
   PubMed Web of Science ®Google Scholar
• Takano T, Ito Y, Matsuzuka F, Miya A, Kobayashi K, Yoshida H, Miyauchi A. (2007). Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma. Jpn J Clin Oncol 37:647–651.
   PubMedGoogle Scholar
• Torbenson M, Wang J, Choti M, Ashfaq R, Maitra A, Wilentz RE, Boitnott J. (2002). Hepatocellular carcinomas show abnormal expression of fibronectin protein. Mod Pathol 15:826–830.
   PubMedGoogle Scholar
• van der Waal I, de Bree R, Brakenhoff R, Coebergh JW. (2011). Early diagnosis in primary oral cancer: Is it possible? Med Oral Patol Oral Cir Bucal 16:e300–e305.
   PubMed Web of Science ®Google Scholar
• Waalkes S, Atschekzei F, Kramer MW, Hennenlotter J, Vetter G, Becker JU, Stenzl A, Merseburger AS, Schrader AJ, Kuczyk MA, Serth J. (2010). Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer. BMC Cancer 10:503.
   PubMedGoogle Scholar
• Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY. (2009). CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 119:1518–1530.
   PubMed Web of Science ®Google Scholar
• Wang Z, Han B, Zhang Z, Pan J, Xia H. (2010). Expression of angiopoietin-like 4 and tenascin C but not cathepsin C mRNA predicts prognosis of oral tongue squamous cell carcinoma. Biomarkers 15:39–46.
   PubMed Web of Science ®Google Scholar
• Wang SJ, Bourguignon LY. (2011). Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol 178:956–963.
   PubMedGoogle Scholar
• Warawdekar UM, Zingde SM, Iyer KS, Jagannath P, Mehta AR, Mehta NG. (2006). Elevated levels and fragmented nature of cellular fibronectin in the plasma of gastrointestinal and head and neck cancer patients. Clin Chim Acta 372:83–93.
   PubMed Web of Science ®Google Scholar
• Wei KC, Huang CY, Chen PY, Feng LY, Wu TW, Chen SM, Tsai HC, Lu YJ, Tsang NM, Tseng CK, Pai PC, Shin JW. (2010). Evaluation of the prognostic value of CD44 in glioblastoma multiforme. Anticancer Res 30:253–259.
   PubMed Web of Science ®Google Scholar
• Williams DA, Rios M, Stephens C, Patel VP. (1991). Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 352:438–441.
   PubMed Web of Science ®Google Scholar
• Yen CY, Liu SY, Chen CH, Tseng HF, Chuang LY, Yang CH, Lin YC, Wen CH, Chiang WF, Ho CH, Chen HC, Wang ST, Lin CW, Chang HW. (2008). Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med 37:271–277.
   PubMed Web of Science ®Google Scholar
• Yen CY, Chen CH, Chang CH, Tseng HF, Liu SY, Chuang LY, Wen CH, Chang HW. (2009). Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers 14:244–249.
   PubMed Web of Science ®Google Scholar
• Zhou J, Nagarkatti PS, Zhong Y, Creek K, Zhang J, Nagarkatti M. (2010). Unique SNP in CD44 intron 1 and its role in breast cancer development. Anticancer Res 30:1263–1272.
   PubMedGoogle Scholar